about
Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitorsCocrystal Structures of Primed Side-Extending α-Ketoamide Inhibitors Reveal Novel Calpain-Inhibitor Aromatic Interactions #Identification of small molecule inhibitors of beta-amyloid cytotoxicity through a cell-based high-throughput screening platform.Disruption of the axon initial segment cytoskeleton is a new mechanism for neuronal injury.Identification and optimization of a novel inhibitor of mitochondrial calpain 10Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytesPeptidyl alpha-ketoamides with nucleobases, methylpiperazine, and dimethylaminoalkyl substituents as calpain inhibitorsDifferent roles for contracture and calpain in calcium paradox-induced heart injury.Comparison of cysteine peptidase activities in Trichobilharzia regenti and Schistosoma mansoni cercariae.Recent advances in proteasome inhibitor discovery.Mechanism of action of thalassospiramides, a new class of calpain inhibitorsDistinct cell death pathways triggered by the adenovirus early region 4 ORF 4 protein.Calpain activity in retinal degeneration.Mechanistic role of calpains in postischemic neurodegeneration.The role of calcium-activated protease calpain in experimental retinal pathology.Limitations of SLLVY-AMC in calpain and proteasome measurementsPhysiologic and pathophysiologic role of calpain: implications for the occurrence of atrial fibrillation.Calpain inhibitors: a survey of compounds reported in the patent and scientific literature.The calpain system and cancer.High molecular weight calmodulin-binding protein: 20 years onwards-a potential therapeutic calpain inhibitor.Calpain-1 inhibitors for selective treatment of rheumatoid arthritis: what is the future?Actinobacterial enzyme inhibitors--a review.An updated patent review of calpain inhibitors (2012 - 2014).Calpain inhibitors reduce retinal hypoxia in ischemic retinopathy by improving neovascular architecture and functional perfusion.Specific knockdown of m-calpain blocks myogenesis with cDNA deduced from the corresponding RNAi.Hypoxia-induced cell death of HepG2 cells involves a necrotic cell death mediated by calpain.Conformationally restricted calpain inhibitors.Synthesis and calpain inhibitory activity of peptidomimetic compounds with constrained amino acids at the P2 position.Structural basis for the potent calpain inhibitory activity of peptidyl alpha-ketoacids.Calpastatin subdomains A and C are activators of calpain.Photoreceptor rescue and toxicity induced by different calpain inhibitors.Calpain activates caspase-3 during UV-induced neuronal death but only calpain is necessary for death.Calpain inhibitors alter the excitable membrane properties of cultured aplysia neurons.Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia.Contribution of calpain to myoglobin efflux from cardiomyocytes during ischaemia and after reperfusion in anaesthetized rats.Calpain inhibitor MDL 28170 protects against the Ca2+ paradox in rat hearts.Use of recombinant calpain-2 siRNA adenovirus to assess calpain-2 modulation of lung endothelial cell migration and proliferation.Synthesis of a 24-Membered Cyclic Peptide-Biphenyl Hybrid
P2860
Q26771736-8CF466E5-25D2-4F04-92D4-33FF7B5A1C09Q27651571-D9508C92-0613-4B08-B2FE-2679FB531092Q33371464-84B716F9-525A-4F79-9A63-CB39AE2F2003Q33570384-0E6A2DD3-68AC-4DB7-970E-AE7CA95B0D22Q33572036-43DE590B-965F-46C7-9BCF-6791DBF38AA8Q33878830-5290EBB5-82DC-499C-A097-0AAE02D7767DQ34194374-515A21AC-7657-487E-9EA6-7FC26E52A028Q34533516-CF77F453-9680-449C-9AB9-C839E07BEF8CQ34630532-2442834A-83AA-4A5C-8BAA-7456FBDE48E4Q34645067-E4EFDD32-ED96-4CFF-981F-709D533F4340Q35148702-41A47706-6EDB-490A-A0D5-380A5E978826Q36325128-A71B9249-AA78-4200-A7D0-0474730F111FQ36685247-AD72431C-34E5-4511-B45C-1487725B4F3DQ37029897-7103FA24-0CF0-46B9-8EA7-2B3C99B1C5B9Q37113015-8BF53CD2-4387-41DA-9E28-631C7FA77FABQ37218606-793F60A7-7CD1-4B59-9B58-6B66FBDE751AQ37812402-9696C917-CD72-4B79-89B5-D4FA01D1ADD8Q37857282-C7186426-C34A-4AA3-9D8F-DB3571195158Q37867486-304B6A20-4563-4B6A-BBFF-5B82EB497173Q38010378-DD806690-5F96-4D9F-88FE-3E5AE07BF152Q38161548-38DBAA02-C0FD-4FA0-B650-2B5F8A8244D6Q38185118-7978FF89-36FB-4DDB-B6D5-4F5178D9C94BQ38268518-F081F02D-D833-4CD1-B5C0-BCC830311B21Q39661641-715D8F80-F4D9-4DA0-9304-9110FA5EDDCFQ40021155-93792A3E-4FCD-40F0-9EB4-83611E796105Q40189051-8DAE37D0-94B9-4467-9815-B85483DF7F6EQ40891311-F7115118-0C37-4DE5-8951-0D224BA424C5Q41846613-00F2A39E-EF0B-4E34-8FBB-50304B15143CQ41940642-73DF2969-C3F0-490E-BDBB-A1226EF5A521Q42668393-33FE02B2-863F-4B6A-A7A5-EB6920194381Q42921231-B233F5A9-D2C2-436A-AB45-A0BC419C85D5Q44163246-489C578E-3F2E-4042-9AFA-3EE6DCD02D1FQ46442267-514332B9-202D-4092-869C-B83B772FCA0AQ46642858-3E3801AF-7683-4EAA-9CFC-A0C5BA99D7A6Q47947432-EA7F54CF-8B0A-418D-AE08-7D9812FD9AFDQ48725567-766A3591-FB1E-4672-9457-28484E40F897Q51190794-B8032397-E1EE-4F05-A01B-CBBA40D5B776Q58035473-75E914D7-77F0-4BA3-8D3D-42028C1F757C
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A survey of calpain inhibitors.
@ast
A survey of calpain inhibitors.
@en
A survey of calpain inhibitors.
@nl
type
label
A survey of calpain inhibitors.
@ast
A survey of calpain inhibitors.
@en
A survey of calpain inhibitors.
@nl
prefLabel
A survey of calpain inhibitors.
@ast
A survey of calpain inhibitors.
@en
A survey of calpain inhibitors.
@nl
P356
P1476
A survey of calpain inhibitors.
@en
P2093
P304
P356
10.2174/0929867003374129
P577
2000-12-01T00:00:00Z